# ORIGEN THERAPEUTICS INC /CA — Form D

ORIGEN THERAPEUTICS INC /CA of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-12. The offering totals $5.4M, of which $3.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-08-12
- Form: D
- Accession: 0001051842-10-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.4M
- Amount sold: $3.7M
- Remaining: $1.7M
- Investors: 8
- Date of first sale: 2010-07-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-146290

## Issuer

- Name: ORIGEN THERAPEUTICS INC /CA
- CIK: 0001051842
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 5885 HOLLIS STREET, EMERYVILLE, CA, 94608
- Phone: 510-597-5140

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| DAVID W CARTER | Director | SOUTH SAN FRANCISCO, CA |
| Timothy W Harris | Director | Emeryville, CA |
| Robert W Kay | Director | Emeryville, CA |
| Spencer W Wang | Director | Emeryville, CA |
| Lynda W Wijcik | Director | Emeryville, CA |
| DAVID W CARTER | Executive Officer | SOUTH SAN FRANCISCO, CA |

## More

- [CIK 1051842 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1051842&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001051842-10-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.